About TRexBio

We believe breakthrough therapeutics for patients with inflammatory diseases are within reach. By targeting the underlying dysregulation that drives disease, our team is identifying and advancing a pipeline of medicines that have the potential to transform how we treat a range of inflammatory conditions.

We Are Decoding Human Tissue Biology to Create Revolutionary Therapeutics

Our goal is to improve the lives of patients living with immune mediated diseases. Current therapies offer some relief to some patients but also come with certain tradeoffs between efficacy, safety, and quality of life. At TRexBio, we believe it’s time for more durable solutions. We are developing biologics that act at the site of inflammation – rebalancing the immune system, promoting tissue repair, and providing additional opportunities to address the unmet needs in autoimmune and inflammatory diseases.

Leadership

We are a team of experienced and passionate scientists, drug development experts, and industry leaders.
We are committed to developing breakthrough medicines by decoding human tissue biology and believe we are well positioned to usher in breakthrough medicines with this approach.